What an F.D.A. Committee Weighed in Ballot for the Pfizer COVID Vaccine

There are things we still do not understand about the COVID-19 vaccine, but whatever we do know looks great. Photo by Ben Birchall/ Swimming Pool/ EPA-EFE/ Shutterstock

An all-day hearing of the Food and Drug Administration’s vaccine advisory committee closed, on Thursday night, with a vote to suggest an Emergency Situation Usage Authorization of the Pfizer-BioNTech COVID-19 vaccine for people sixteen and older. An F.D.A. analysis of the raw information, released previously this week, confirmed previous reports that the vaccine’s efficacy in avoiding illness in trial participants was close to ninety-five per cent.

https://cnacertificationcourses.net/what-an-f-d-a-committee-weighed-in-ballot-for-the-pfizer-covid-vaccine/